Cardiopulmonary Diseases CEU Courses for Respiratory Therapists

Respiratory therapists and rehabilitation providers working in a variety of settings in the community will likely encounter individuals living with Long COVID. This course provides clinicians with guidance on how Long COVID may present in their patients, how to screen for red flags, and what entails safe rehabilitation for this population based on current guidelines.

This course provides participants with an overview of the purpose and objectives of the GOLD guidelines for COPD. The discussion provides COPD assessment and diagnosis, helping to gain an understanding of these critical aspects to proficiently identify patients in accordance with the GOLD guidelines, and for the application of tailored treatment strategies for both stable COPD and COPD exacerbations.

This course reviews the spectrum of connective tissue disease (CTD) and associated interstitial lung diseases (ILD) from epidemiology and prognosis. We discuss essential diagnostic testing for an accurate diagnosis and current and future therapeutics.

This course addresses the challenges faced by the respiratory therapist in engaging patients with end-stage COPD. Legal and ethical issues, as well as practical approaches to engaging patients with end-state COPD, is discussed.

Silent hypoxia occurs in some COVID-19 patients affecting breathing perception and dyspnea. This course discusses the silent hypoxemia’s relationship between ventilatory drive, cardiovascular decline, and the phenomenon of sudden death.

Clinical experts comprised a multi-professional panel to conduct a systematic review to address patients with neuromuscular diseases (NMD). A review of evidenced-based grading of recommendations and management of patients with NMD is discussed. It is part of an NMD series but can be viewed as a stand-alone learning experience.

An essential concern in neuromuscular diseases (NMD) is respiratory failure. This course reviews guidelines and evidenced-based literature on the best practice respiratory management of patients with NMD. It is part of an NMD series but can be viewed as a stand-alone learning experience.

We largely think about mechanical ventilation focused on the future, at the cost of not appreciating how past practices still influence current understanding about the care we give: often to our detriment. This lecture is a story of how we arrived at this moment and describes how artificial intelligence might revolutionize how we deliver care in the near future.

This course reviews the current options for asthma and COPD medication delivery devices. The course discusses standard devices available, techniques, and usage.

Interstitial lung diseases (ILD) are an important, increasingly recognized group of inflammatory and fibrotic lung diseases that pose diagnostic and therapeutic challenges. A multidisciplinary approach to patient-centered care is essential.